Status:

TERMINATED

OCT-guided LALAK for KCN

Lead Sponsor:

Oregon Health and Science University

Collaborating Sponsors:

National Institutes of Health (NIH)

National Eye Institute (NEI)

Conditions:

Corneal Opacity

Keratoconus

Eligibility:

All Genders

18-100 years

Phase:

NA

Brief Summary

The purpose of this study is to determine if a new procedure, called laser-assisted lamellar anterior keratoplasty (LALAK), can achieve the same level of vision with a lower risk of potential complica...

Detailed Description

Corneal transplantation (keratoplasty) is the most common organ transplant, with 42,606 procedures in the U.S. in 2009. Many surgeons are moving away from full thickness corneal transplantation, also ...

Eligibility Criteria

Inclusion

  • Eyes with keratoconus that cannot be adequately or safely corrected with spectacles, contact lens or excimer laser surface ablation. The cornea must have healthy endothelium (endothelial cell density \> 1,500/mm2).

Exclusion

  • Preoperative corneal thickness less than 400 microns.
  • Corneal edema
  • Central guttata
  • Inability to give informed consent.
  • Inability to maintain stable fixation for OCT imaging.
  • Inability to commit to required visits to complete the study.
  • Eyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery.
  • Patients with severe collagen vascular diseases or ocular surface disorders

Key Trial Info

Start Date :

August 1 2013

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

August 31 2017

Estimated Enrollment :

5 Patients enrolled

Trial Details

Trial ID

NCT01901614

Start Date

August 1 2013

End Date

August 31 2017

Last Update

January 23 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Casey Eye Institute, Oregon Health & Science University

Portland, Oregon, United States, 97239